Pages that link to "Q39260698"
Jump to navigation
Jump to search
The following pages link to The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups (Q39260698):
Displaying 9 items.
- Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes (Q39359422) (← links)
- In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease (Q47553772) (← links)
- Nanotechnology as a Delivery Tool for Precision Cancer Therapies (Q50091869) (← links)
- Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition. (Q52431312) (← links)
- Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infection. (Q55088655) (← links)
- The potential of CRISPR/Cas9 genome editing for the study and treatment of intervertebral disc pathologies (Q57729296) (← links)
- Functional Genomics via CRISPR-Cas (Q89360903) (← links)
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population (Q90727473) (← links)
- Drug Delivery System in the Treatment of Diabetes Mellitus (Q98771601) (← links)